15.06.2021 Geratherm Medical AG  DE0005495626

DGAP-News: Geratherm Medical AG: Subsidiary apoplex medical and Telekom: Together against stroke


 

DGAP-News: Geratherm Medical AG / Key word(s): Alliance
Geratherm Medical AG: Subsidiary apoplex medical and Telekom: Together against stroke

15.06.2021 / 11:11
The issuer is solely responsible for the content of this announcement.


Corporate News

Geratherm Medical AG, Geratal, 15.06.2021

Subsidiary apoplex medical and Telekom: Together against stroke

- Telekom enables digital stroke-risk-analysis

- Cooperation with apoplex medical technologies

- Data is hosted in the Telekom Healthcare Cloud

______________________________________________________________

Strokes are one of the most common causes of death in Germany. Around 270,000 people suffer a stroke every year. Telekom is supporting the fight against this "widespread disease" in cooperation with apoplex medical technologies. The mid-sized medical technology company from Pirmasens offers a software-based solution that helps to detect the risk factor atrial fibrillation at an early stage and thus prevent strokes. Telekom and apoplex now jointly offer a solution for early Stroke-Risk- Analysis (SRA(R)) in the cloud.

"We want our technology to help reduce the number of stroke patients in the future," says Michael Waldbrenner, Managing Director of Telekom Healthcare Solutions. To this end, the digital SRA(R) will be operated in the Telekom Healthcare Cloud in the future. Doctors can use the SRA(R) application to screen patient ECGs for unknown atrial fibrillation and thus reduce a possible stroke risk with appropriate therapeutic measures. More than 200 clinics are already using the diagnostic software. "Our customers particularly appreciate the increase in diagnostic quality and the associated optimization of clinic processes," explains apoplex Managing Director Albert Hirtz.

Cloud with "ideal conditions"
The software is an approved medical device that can be securely operated in the Telekom Healthcare Cloud. The cloud can also be used by professional secrecy holders within the meaning of Section 203 of the German Criminal Code (StGB) to store and process data requiring special protection. "The Telekom Healthcare Cloud offers ideal conditions for us, as it meets both the requirements of the Federal Office for Security and Information Technology and those of European data protection, so that doctors can also use it without hesitation when processing medical data," says Albert Hirtz. "We are in the implementation phase and will move the first customers to the cloud in early August."

With the Telekom Healthcare Cloud, Telekom provides companies and healthcare institutions a platform for the flexible, secure, and modular procurement of IT resources. The group' s customers include clinics, insurance companies and medical start-ups.

apoplex medical technologies GmbH was founded in 2004 in Pirmasens, West Palatinate Germany, and specializes in new and innovative technology products for stroke prevention in the field of medical technology for worldwide use. The daughter company of Geratherm Medical AG focuses on easy-to-use and efficient methods of so-called patient screening by means of medical technology applications for the prevention of stroke and vascular dementia. The SRA (Stroke-Risk-Analysis) procedure is the first practicable screening procedure for paroxysmal atrial fibrillation. apoplex medical technologies is supported by an extensive academic and clinical network that complements its core competencies in mathematics, physics and medicine. More information is available at https://apoplexmedical.com.

Geratherm Medical AG
Fahrenheitstraße 1
99331 Geratal
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-115
E-Mail: [email protected]
Web: www.geratherm.com

Firmensitz: Fahrenheitstraße 1, 99331 Geratal / GERMANY
Vorstand: Dipl.-Kfm. Christian Frick
Aufsichtsratsvorsitzender: Dr. Gert Frank
Registergericht: Amtsgericht Jena HRB 111 272

Short company profil:
Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MRI Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index.

 




Contact:
Dr. Gert Frank


15.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
99331 Geratal
Germany
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: [email protected]
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1208131

 
End of News DGAP News Service

1208131  15.06.2021 

fncls.ssp?fn=show_t_gif&application_id=1208131&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 21,59 21,41 21,03 21,52 19,85 27,47 28,90
EBITDA1,2 3,42 3,71 1,77 2,80 2,35 4,35 5,00
EBITDA-Marge3 15,84 17,33 8,42 13,01 11,84 15,84 17,30
EBIT1,4 2,53 2,54 0,63 1,99 1,05 3,04 3,60
EBIT-Marge5 11,72 11,86 3,00 9,25 5,29 11,07 12,46
Jahresüberschuss1 2,39 2,25 0,22 0,83 0,29 1,90 2,50
Netto-Marge6 11,07 10,51 1,05 3,86 1,46 6,92 8,65
Cashflow1,7 3,77 0,79 2,47 1,35 1,54 3,92 4,55
Ergebnis je Aktie8 0,55 0,45 0,14 0,23 0,11 0,41 0,48
Dividende8 0,50 0,50 0,47 0,40 0,25 0,40 0,42
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Geratherm Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
549562 9,200 Kaufen 45,54
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
13,73 25,11 0,54 27,63
KBV KCV KUV EV/EBITDA
2,54 11,63 1,66 10,28
Dividende '19 in € Dividende '20e in € Div.-Rendite '20e
in %
Hauptversammlung
0,25 0,40 4,35 11.06.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
20.05.2021 25.08.2021 24.11.2021 28.04.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-5,92% -16,38% -15,60% -17,12%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Geratherm Medical AG  ISIN: DE0005495626 können Sie bei DGAP abrufen

Medtech , 549562 , GME , XETR:GME